Gail M. Annich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gail M. Annich has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ali B. V. McMichael
Division of Critical Care Medicine Phoenix Children's Phoenix Arizona USA
1 shared publication Andrés Castillo Moya
Department of Pediatrics, Pontificia Universidad Católica de Chile, Santiago, Chile
1 shared publicationB Bryner
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
1 shared publicationC Smith
Department of Surgery, University of Michigan, Ann Arbor, Michigan
1 shared publicationChristina Maratta
Interdivisional Department of Critical Care Medicine, University of Toronto, Ontario, Canada
1 shared publicationE Cooley
Extracorporeal Life Support Program, University of Michigan, Ann Arbor, Michigan
1 shared publication
Latest Publications
- Open Access
- 19 May 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 69 (1) , e53
More to Learn About Acquired Von Willebrand Syndrome
- 19 May 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 69 (1) , e53
Open AccessMore to Learn About Acquired Von Willebrand Syndrome
- 14 July 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 66 (9) , 975-979
Extracorporeal Life Support Organization (ELSO): 2020 Pediatric Respiratory ELSO Guideline
Disclaimer: This guideline describes prolonged extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO), applicable to Pediatric respiratory failure. These guidelines describe useful and safe practice, prepared by ELSO and based on extensive experience and are considered consensus guidelines. These guidelines are not intended to define standard of care and are revised at regular intervals as new information, devices, medications, and techniques become available.
- 14 July 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 66 (9) , 975-979
Extracorporeal Life Support Organization (ELSO): 2020 Pediatric Respiratory ELSO Guideline
Disclaimer: This guideline describes prolonged extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO), applicable to Pediatric respiratory failure. These guidelines describe useful and safe practice, prepared by ELSO and based on extensive experience and are considered consensus guidelines. These guidelines are not intended to define standard of care and are revised at regular intervals as new information, devices, medications, and techniques become available.
- Open Access
- 17 July 2013
- Published by SAGE Publications in Perfusion
- Vol. 29 (1) , 39-43
Extracorporeal life support for acute respiratory distress syndrome due to severe Legionella pneumonia
Legionella is a common cause of community-acquired pneumonia (CAP) and is second only to Pneumococcal pneumonia as a cause of severe CAP that requires treatment in an intensive care unit. We report a case series of patients with severe Legionella pneumonia who developed the acute respiratory distress syndrome (ARDS), failed to improve with mechanical ventilation alone and required extracorporeal life support (ECLS). We performed a retrospective study of all patients treated with ECLS at our institution for severe ARDS as a result of Legionella pneumonia from 1994 to 2006. A total of twelve patients with a diagnosis of Legionella pneumonia were treated with veno-venous (VV) ECLS over this time period. Nine of these twelve (75%) were successfully treated and weaned off ECLS and 8 patients (67%) survived to hospital discharge. Two (13%) died of multisystem organ failure, one patient (8%) died from global hypoxic encephalopathy and one (8%) was weaned from ECLS, but ultimately died of liver failure. Renal failure requiring some form of continuous dialysis occurred in seven patients (58%) and the survival for this sub-set of patients was 43%. Extracorporeal life support for severe ARDS associated with Legionella pneumonia is an effective treatment option when mechanical ventilation fails, especially when introduced early in the course.
- 17 July 2013
- Published by SAGE Publications in Perfusion
- Vol. 29 (1) , 39-43
Open AccessExtracorporeal life support for acute respiratory distress syndrome due to severe Legionella pneumonia
Legionella is a common cause of community-acquired pneumonia (CAP) and is second only to Pneumococcal pneumonia as a cause of severe CAP that requires treatment in an intensive care unit. We report a case series of patients with severe Legionella pneumonia who developed the acute respiratory distress syndrome (ARDS), failed to improve with mechanical ventilation alone and required extracorporeal life support (ECLS). We performed a retrospective study of all patients treated with ECLS at our institution for severe ARDS as a result of Legionella pneumonia from 1994 to 2006. A total of twelve patients with a diagnosis of Legionella pneumonia were treated with veno-venous (VV) ECLS over this time period. Nine of these twelve (75%) were successfully treated and weaned off ECLS and 8 patients (67%) survived to hospital discharge. Two (13%) died of multisystem organ failure, one patient (8%) died from global hypoxic encephalopathy and one (8%) was weaned from ECLS, but ultimately died of liver failure. Renal failure requiring some form of continuous dialysis occurred in seven patients (58%) and the survival for this sub-set of patients was 43%. Extracorporeal life support for severe ARDS associated with Legionella pneumonia is an effective treatment option when mechanical ventilation fails, especially when introduced early in the course.